New Approaches to Measuring Value in Oncology Therapy
Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 Vaccination Linked to Lower Risk of Long COVID in Adolescents
2
Role of MRAs in Heart Failure Treatment
3
Breast Cancer Dominating Oncology Research, Access Disparities: Gen Li, PhD
4
Nearly All US Youth With BMI-Defined Obesity Have Excess Adiposity
5
